Perha Pharmaceuticals is a bio technology company which does research & development of kinase inhibitors.
Perha Pharmaceuticals has raised $2.8M in total funding. The most recent round was Grant. The last funding was announced in March 2022.
Perha Pharmaceuticals's investors include Bpifrance, European Innovation Council, Fondation Jerome Lejeune.
Perha Pharmaceuticals is headquartered in Roscoff, France.
Perha Pharmaceuticals is a bio technology company which does research & development of kinase inhibitors.
Perha Pharmaceuticals is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Perha Pharmaceuticals — Funding & Investors." VCBacked, March 23, 2022, https://www.vcbacked.co/company/perha-pharmaceuticals. Accessed October 19, 2026.
VCBacked. (2022). Perha Pharmaceuticals — Funding & Investors. Retrieved October 19, 2026, from https://www.vcbacked.co/company/perha-pharmaceuticals
{{cite web |title=Perha Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/perha-pharmaceuticals |website=VCBacked |access-date=October 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated